Sanofi India inks MoU with NIPER Kolkata

17 Nov 2016 Evaluate

Sanofi India (SIL) has signed a Memorandum of Understanding (MoU) with NIPER Kolkata, an autonomous body set up under the aegis of Department of Pharmaceuticals, Government of India, to promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the Pharmaceutical industry.

Through this initiative, Sanofi India will participate in revision or formulation of curriculum for a Post-Graduate (M.S.)/Ph.D. rogramme; provide opportunities of internship or project work to NIPER Kolkata M.S./Ph.D. students at manufacturing sites; ensure association of R&D heads with the dissertation work of NIPER Students; provide career growth opportunities; and undertake collaborative research activities in identified areas.

As per the MoU, the key deliverables for Sanofi India will be to assist NIPER Kolkata foster students with updated knowledge, and who are ready for the pharmaceutical industry.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.

Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.